US Patent Issued to Dompe' Farmaceutici SPA on May 26 for "CXCL8 inhibitors for use in the treatment of COVID-19" (Italian Inventors)

ALEXANDRIA, Va., May 26 -- United States Patent no. 12,636,268, issued on May 26, was assigned to Dompe' Farmaceutici SPA (Milan).

"CXCL8 inhibitors for use in the treatment of COVID-19" was invented by Marcello Allegretti (L'Aquila, Italy), Flavio Mantelli (L'Aquila, Italy) and Lorenzo Piemonti (Milan).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to CXCL8 inhibitors for use in the treatment of COVID-19 patients with pneumonia."

The patent was filed on March 24, 2021, under Application No. 17/914,529.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-b...